Nvidia, $NVDA, has announced AI-powered health care 'agents' that outperform nurses — and cost $9 an hour, per FOX.
Nvidia, a leading chipmaker, has partnered with Hippocratic AI, an artificial intelligence healthcare company, to develop generative AI "agents" that not only surpass human nurses in video calls but also cost significantly less per hour.
The collaboration, announced on Thursday, aims to create "empathetic healthcare agents" powered by Nvidia and trained on Hippocratic's healthcare-focused large language model (LLM). These agents are designed to establish a more human connection with patients through "super-low latency conversational reactions."
Hippocratic's agents have undergone testing by over 1,000 registered nurses and 100 licensed physicians in the U.S. Dozens of healthcare providers are currently using the bots internally for non-diagnostic tasks.
According to Hippocratic, its bots outperform competitors such as OpenAI's GPT-4 and the LLaMA 2 70B Chat, and have even outperformed human nurses in various categories tested.
The company's Constellation model surpassed real nurses by 79% to 63% in identifying a medication's impact on lab values, 88% to 45% in identifying condition-specific disallowed over-the-counter medications, 96% to 93% in correctly comparing a lab value to a reference range, and 81% to 57% in detecting toxic dosages of over-the-counter drugs.
Munjal Shah, co-founder and CEO of Hippocratic AI, stated, "We're collaborating with NVIDIA to further refine our technology and amplify the impact of our work in mitigating staffing shortages while enhancing access, equity, and patient outcomes."
FEATURED NEWS
US lawmakers have urged SEC to delist Alibaba, BABA, and other Chinese companies
5/3/2025 Buffett and Berkshire now have $347.7 Billion of cash and cash equivalents as of the end of Q1 ...
5/3/2025 Warren Buffett has downplayed recent market volatility as 'really nothing,' saying it's part of...
5/3/2025 Warren Buffett says he will retire at the end of the year from Berkshire Hathaway
5/3/2025
Stay Updated
Subscribe to our newsletter for the latest financial insights and news.
